• DNA X filed Form 12b-25 to delay its quarterly report on Form 10-Q for period ended March 31, 2026.
• Filing slipped due to accounting work tied to sale of legacy mobile phone and hotspot business, including discontinued-operations presentation, recasting prior-period comparatives, and calculating gain or loss on disposition.
• Form 10-Q expected on or before fifth calendar day after original due date.
• Net loss from continuing operations expected at about $3.6 million, versus $0.7 million a year earlier.
• Wider loss attributed to higher general and administrative costs from severance and bonus payments tied to sale, alongside higher professional fees.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DNA X Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-023793), on May 15, 2026, and is solely responsible for the information contained therein.